Harbour BioMed Appoints Mr. Weihao Xu as Chief Strategy Officer

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China: CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, Dec. 2, 2021 /PRNewswire/ -- Harbour BioMed ("HBM", HKEX:02142) is pleased to announce the appointment of Mr. Weihao Xu as Chief Strategy Officer (CSO), who will base in San Francisco. Mr. Xu will be...

Click to view original post